Broker Research
June 12, 2025 / 11:39 IST
Reported Standalone quarterly numbers for ANG Lifesciences India are:Net Sales at Rs 17.67 crore in March 2025 down 48.16% from Rs. 34.08 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 1.94 crore in March 2025 up 46.2% from Rs. 3.60 crore in March 2024.
EBITDA stands at Rs. 0.39 crore in March 2025 down 90.46% from Rs. 4.09 crore in March 2024.
ANG Lifescience shares closed at 30.50 on June 11, 2025 (BSE) and has given -35.75% returns over the last 6 months and -43.25% over the last 12 months.
| ANG Lifesciences India | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 17.67 | 23.91 | 34.08 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 17.67 | 23.91 | 34.08 | | EXPENDITURE | | Consumption of Raw Materials | 11.57 | 16.85 | 30.29 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.26 | -0.71 | -7.69 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.44 | 3.72 | 3.67 | | Depreciation | 1.30 | 1.84 | 1.83 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 2.76 | 6.03 | 3.97 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.66 | -3.82 | 2.01 | | Other Income | 0.75 | -0.03 | 0.25 | | P/L Before Int., Excpt. Items & Tax | -0.91 | -3.85 | 2.26 | | Interest | 2.05 | 1.71 | 3.44 | | P/L Before Exceptional Items & Tax | -2.96 | -5.56 | -1.18 | | Exceptional Items | -- | -- | -1.74 | | P/L Before Tax | -2.96 | -5.56 | -2.91 | | Tax | -1.02 | -1.00 | 0.69 | | P/L After Tax from Ordinary Activities | -1.94 | -4.57 | -3.60 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.94 | -4.57 | -3.60 | | Equity Share Capital | 13.06 | 13.06 | 13.06 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.50 | -3.50 | -2.73 | | Diluted EPS | -1.50 | -3.50 | -2.73 | | EPS After Extra Ordinary | | Basic EPS | -1.50 | -3.50 | -2.73 | | Diluted EPS | -1.50 | -3.50 | -2.73 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
